We are live on ! Find out more
GCP

GSA Capital Partners Portfolio holdings

AUM $1.59B
1-Year Est. Return 39.81%
This Fund
S&P 500
This Quarter Est. Return
-2.76%
1 Year Est. Return
+39.81%
3 Year Est. Return
+94.75%
5 Year Est. Return
+73.44%
10 Year Est. Return
+404.29%
AUM
$754M
AUM Growth
+$87.8M
Cap. Flow
+$160M
Cap. Flow %
21.21%
Top 10 Hldgs %
3.31%
Holding
2,028
New
691
Increased
437
Reduced
328
Closed
568

Sector Composition

Rank Sector Weight
1 Healthcare 16.63%
2 Consumer Discretionary 15.71%
3 Technology 14.34%
4 Industrials 12%
5 Financials 11.51%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WIX icon
426
WIX.com
WIX
$2.52B
$611K 0.08%
+7,805
New +$538K
EGRX
427
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
$611K 0.08%
23,137
+6,081
+36% +$223K
AHCO icon
428
AdaptHealth
AHCO
$759M
$610K 0.08%
+32,497
New +$668K
FWRD icon
429
Forward Air
FWRD
$654M
$610K 0.08%
6,757
+2,352
+53% +$231K
LOW icon
430
Lowe's Companies
LOW
$125B
$610K 0.08%
3,247
+1,301
+67% +$253K
PBH icon
431
Prestige Consumer Healthcare
PBH
$2.6B
$610K 0.08%
12,247
+5,457
+80% +$302K
HZNP
432
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$608K 0.08%
9,824
+4,212
+75% +$294K
CB icon
433
Chubb
CB
$135B
$607K 0.08%
+3,339
New +$634K
ATCX
434
DELISTED
Atlas Technical Consultants, Inc. Class A Common Stock
ATCX
$607K 0.08%
91,340
+51,222
+128% +$367K
HOV icon
435
Hovnanian Enterprises
HOV
$807M
$606K 0.08%
+16,968
New +$751K
REGN icon
436
Regeneron Pharmaceuticals
REGN
$80.8B
$606K 0.08%
880
+350
+66% +$220K
IMPP icon
437
Imperial Petroleum
IMPP
$208M
$605K 0.08%
+124,205
New +$706K
RL icon
438
Ralph Lauren
RL
$23.6B
$605K 0.08%
7,129
+212
+3% +$20K
LENZ
439
LENZ Therapeutics
LENZ
$168M
$605K 0.08%
27,243
+12,621
+86% +$301K
CHH icon
440
Choice Hotels
CHH
$4.8B
$603K 0.08%
+5,504
New +$631K
VKTX icon
441
Viking Therapeutics
VKTX
$4B
$602K 0.08%
221,483
+54,127
+32% +$177K
CDNS icon
442
Cadence Design Systems
CDNS
$93.4B
$601K 0.08%
+3,678
New +$632K
LH icon
443
Labcorp
LH
$25.9B
$599K 0.08%
3,407
+1,786
+110% +$366K
UMBF icon
444
UMB Financial
UMBF
$11.1B
$599K 0.08%
7,104
-1,245
-15% -$113K
APLE icon
445
Apple Hospitality REIT
APLE
$3.82B
$598K 0.08%
42,516
+31,056
+271% +$493K
TDC icon
446
Teradata
TDC
$2.55B
$597K 0.08%
+19,234
New +$672K
EVRI
447
DELISTED
Everi Holdings
EVRI
$596K 0.08%
36,749
+6,720
+22% +$124K
ATHM icon
448
Autohome
ATHM
$2.62B
$594K 0.08%
+20,668
New +$720K
MCB icon
449
Metropolitan Bank Holding Corp
MCB
$1.15B
$593K 0.08%
+9,207
New +$653K
JBSS icon
450
John B. Sanfilippo & Son
JBSS
$972M
$592K 0.08%
+7,823
New +$591K

Similar funds

GSA Capital Partners's Q3 2022 Portfolio in Review

As of Q3 2022, GSA Capital Partners held 2,028 positions worth $754M, up 13% from $666M the previous quarter. Its ten largest holdings account for 3.3% of the portfolio.

GSA Capital Partners deployed $160M of net new capital in Q3 2022, opening 691 new positions and adding to 437 existing holdings. Its largest new stake was Dave & Buster's: 75,954 shares worth $2.36M.

By sector, the portfolio is most concentrated in Healthcare at 17% of assets, down from 18% a quarter earlier, followed by Consumer Discretionary and Technology.

On the sell side, the largest reduction was Genpact, an estimated $3.61M trimmed.

  • GSA Capital Partners's largest Q3 2022 buy was Dave & Buster's: 75,954 shares worth $2.36M.
  • GSA Capital Partners added most to Grocery Outlet in Q3 2022, an estimated $2.54M increase.
  • GSA Capital Partners's biggest Q3 2022 reduction was Genpact, cutting an estimated $3.61M.
  • GSA Capital Partners fully exited Relay Therapeutics in Q3 2022, selling an estimated $2.99M.
  • GSA Capital Partners's ten largest holdings make up 3.3% of its $754M portfolio in Q3 2022.
  • GSA Capital Partners opened 691 new positions and closed 568 in Q3 2022.
  • GSA Capital Partners's portfolio value rose 13% quarter-over-quarter to $754M.

Based on GSA Capital Partners's 13F filing for Q3 2022, filed 14 Nov 2022.